Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ORGANIZATION
ORGANIZATION
- JGA President Sawai Promises to Ensure Quality and Secure Stable Supply of Generics
January 24, 2013
- JPMA Bolstering ICH Activities to Propose New Topics from Industry
January 18, 2013
- JPMA Approves New “Code of Practice”
January 18, 2013
- JPA Expresses Deep Regrets over Court Ruling on Online Sale of OTC Drugs
January 16, 2013
- JMA Vice Pres. Nakagawa Urges Pharmacies to Rigidly Check Medical Exam History of Epadel OTC Buyers
January 15, 2013
- JMA Sets Up “Council on Medical COI” Out of Concerns Over Transparency GL
January 11, 2013
- JPWA Chief Bessho Calls for Clearer Rule for Sales Tax on Ethical Drugs
January 10, 2013
- Efforts to Promote Generic Substitution Preferable to Cutting Prices of Long-Listed Drugs: Mr Sawai of JGA
January 8, 2013
- Member Companies to Begin Enforcing New COP in FY2013: JPMA President Teshirogi
January 7, 2013
- JPMA to Ask Abe Administration to Continue Former Dialogue with Pharmaceutical Industry: Dr Teshirogi
January 7, 2013
- NHO to Review Calculation Method for Clinical Trial Costs
December 28, 2012
- JPA to Hold Workshops to Train Pharmacists to Make Clinical Assessments Based on Subjective Symptoms
December 26, 2012
- JMA to Discuss JPMA’s Transparency Guidelines with JPMA, Related Medical Organizations
December 25, 2012
- “New Administration Needed to Allocate Personnel to Cabinet, LDP to Work Out Challenges”: Keizai Doyukai Chair Hasegawa
December 19, 2012
- Generic Market Share at 25.4% in 2nd Quarter on Volume Basis: JGA
December 14, 2012
- Tohoku Pharmaceutical Univ. to Acquire Tohoku Kosei Nenkin Hospital, Aiming to Turn It into Model Hospital for Pharmaceutical Education
December 14, 2012
- Panelists at IGPA Conference Express Concern that FTA Could Strengthen Intellectual Property Rights
December 10, 2012
- GIST Patients Group Submits Petition Calling for Early Filing for Regorafenib for GIST
December 10, 2012
- Kyoto Declaration Calls for Strict Quality Control of Generics: IGPA Annual Conference
December 10, 2012
- Biosimilars Popular Topic at IGPA Annual Conference
December 10, 2012
ページ
Japan’s plasma-derived product industry is approaching a turning point as the government prepares to step in with unprecedented support for…
The Wednesday TableShe had been on virtual calls since eight in the morning. The screen glowed. Her eyes burned. Plugged into Teams across time zones, she was digitally connected yet entirely isolated from the reality of Japan’s pharma market.She needed…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…